National Graphite Corp. (NGRC)의 가격은 얼마입니까?

National Graphite Corp. (NGRC)의 가격은 $0.021입니다.

National Graphite Corp. (NGRC)의 시가 총액은 무엇입니까?

National Graphite Corp. (NGRC)의 시가 총액은 $3.24M입니다.

National Graphite Corp. (NGRC) 영업이익률

National Graphite Corp. (NGRC), operating through its subsidiary Biotech Development Corp., functions as a biopharmaceutical enterprise specializing in risk and cost-sharing models. The company establishes partnerships with clinical-stage firms dedicated to developing novel biological entities or innovative therapeutic platforms. These collaborations aim to address a wide spectrum of health conditions, encompassing common illnesses, rare disorders, and those with significant unmet medical requirements. Among its key pipeline developments is ELAFIN, a drug candidate identified as a human-identical protein. ELAFIN is being developed specifically for the management of postoperative inflammatory complications. The advancement of ELAFIN is further supported by a collaboration agreement with Proteo Inc. Founded in 2006, National Graphite Corp. was formerly known as Lucky Boy Silver Corporation until it officially adopted its current name in May 2012. The company maintains its operational headquarters in Duesseldorf, Germany.

연도	영업이익률	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

영업이익률

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	영업이익률	영업이익률 차이	국가
Clone Algo Technologies Inc. CATI.US	0.00%	-	US
Worldwide Webb Acquisition Corp. WWAC.US	0.00%	-	US
Gushen, Inc. GSHN.US	0.00%	-	CN
Apollo Strategic Growth Capital APSG.US	0.00%	-	US
Digital World Acquisition Corp. DWAC.US	0.00%	-	US

회사

영업이익률

영업이익률 차이

국가